Long-term clinical efficacy of grass-pollen immunotherapy.

@article{Durham1999LongtermCE,
  title={Long-term clinical efficacy of grass-pollen immunotherapy.},
  author={S. Durham and S. Walker and E. Varga and M. Jacobson and F. O'Brien and W. Noble and S. Till and Q. Hamid and K. Nouri-Aria},
  journal={The New England journal of medicine},
  year={1999},
  volume={341 7},
  pages={
          468-75
        }
}
  • S. Durham, S. Walker, +6 authors K. Nouri-Aria
  • Published 1999
  • Medicine
  • The New England journal of medicine
    • BACKGROUND Pollen immunotherapy is effective in selected patients with IgE-mediated seasonal allergic rhinitis, although it is questionable whether there is long-term benefit after the discontinuation of treatment. METHODS We conducted a randomized, double-blind, placebo-controlled trial of the discontinuation of immunotherapy for grass-pollen allergy in patients in whom three to four years of this treatment had previously been shown to be effective. During the three years of this trial… CONTINUE READING
    View PDF
    1,195 Citations
    Highly Influential Citations
    14
    Background Citations
    268
    Methods Citations
    11
    Results Citations
    6
    1,195 Citations
    Citation Type

    Citation Type

    Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    • 27
    Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies.
    • 256
    • PDF
    Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.
    • 303
    Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
    • 22
    Long-term allergen-specific immunotherapy correlates with long-term allergen-specific immunological tolerance
    • 7
    Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity.
    • 277
    • PDF
    Long-term Efficacy of House Dust Mite Immunotherapy in Bronchial Asthma: A 15-year Follow-up Study
    • 3
    Twenty years’ observation of subcutaneous pollen allergoid immunotherapy efficacy in adults
    • 2
    • PDF
    Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis.
    • 324
    • PDF
    Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    • 36

    References

    SHOWING 1-10 OF 83 REFERENCES
    Grass pollen immunotherapy: efficacy and safety during a 4‐year follow‐up study
    • 152
    Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs.
    • 360
    • PDF
    Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis
    • 242
    A double-blind study of the discontinuation of ragweed immunotherapy.
    • 74
    Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis.
    • 97
    Does the effect of immunotherapy last after termination of treatment?
    • 125
    Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.
    • 478
    • PDF
    A double‐blind, placebo‐controlled study of immunotherapy with grass‐pollen extract Alutard SQ during a 3–year period with initial rush immunotherapy
    • 113
    Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.
    • 408
    A controlled trial of immunotherapy for asthma in allergic children.
    • 294